Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-κB pathway

Keyphrases

• Angiotensin II (Ang II) 18%
• Angiotensin II Type 1 Receptor (AT1R) 100%
• Angiotensin II Type 1 Receptor Blocker 9%
• AT2R 27%
• Beta-blockers 54%
• C57BL 9%
• Capillary 9%
• Concanavalin A (Con A) 9%
• Dehydroxymethylepoxyquinomicin (DHMEQ) 36%
• Diabetes 100%
• Diabetic Retina 9%
• Diabetic Retinopathy Treatment 9%
• Expression Level 9%
• High Glucose 9%
• Immunohistochemistry 9%
• In Vivo Applications 9%
• Inflammatory Parameters 9%
• Intercellular Adhesion molecule-1 (ICAM-1) 36%
• Labeling Method 9%
• Lectin 9%
• Leukocyte Adhesion 9%
• Leukocytes 9%
• Monocyte Chemoattractant protein-1 (MCP-1) 18%
• MRNA Level 18%
• Nuclear factor-B 100%
• Nuclear Translocation 18%
• PD123319 18%
• Per Se 9%
• Perfusion 9%
• Protein Level 18%
• Quantitative PCR 18%
• RB Pathway 100%
• Renin-angiotensin System 27%
• Retinal Inflammation 100%
• Retinal Vasculature 9%
• System Components 18%
• Telmisartan 9%
• Valsartan 9%
• Vascular Endothelial Growth Factor 18%
• Western Blot 9%

Pharmacology, Toxicology and Pharmaceutical Science

• 1 (4 Dimethylamino 3 Methylbenzyl) 5 Diphenylacetyl 4,5,6,7 Tetrahydro 1h imidazo[4,5 C]pyridine 6 Carboxylic Acid 25%
• Alternative Complement Pathway C3 C5 Convertase 100%
• Angiotensin 37%
• Angiotensin 1 Receptor Antagonist 12%
• Angiotensin II 100%
• C57BL 6 Mouse 12%
• Concanavalin A 12%
• Dehydroxymethylepoxyquinomicin 50%
• Diabetes Mellitus 12%
• Diabetic Retinopathy 12%
• Enzyme-Linked Immunosorbent Assay 12%
• Intercellular Adhesion Molecule 1 50%
• Lectin 12%
• Monocyte Chemotactic Protein 1 25%
• Nuclear Factor 100%
• Receptor 100%
• Renin 37%
• Retinitis 100%
• Telmisartan 12%
• Valsartan 12%
• Vasculotropin 25%
• Western Blot 12%